Cincinnati, Ohio (PRWEB) July 06, 2011
Burg Simpson Eldredge Hersh & Jardine, P.C., and Cohen & Malad, LLP of Indianapolis have filed a nationwide class action lawsuit against CVS Caremark, the largest pharmacy health care provider in the United States and the owners of CVS.com, for allegedly double-billing its customers for the price of prescription drugs.
The Complaint alleges that CVS’s nationwide billing system double-bills the price of prescription drugs to CVS customers who have a high deductible health plan that is coupled with a health reimbursement account or health savings account (HSA) and who use a prescription drug coupon. CVS’s billing system isn’t equipped to handle this coordination of benefits, and as a result, CVS uniformly double-bills these customers––taking cash from the customer at the time of sale and then later taking cash from their HSA.
The class action lawsuit was filed in state court in Cincinnati on July 5, 2011. It brings class action claims on behalf of all CVS customers who were allegedly double-billed the price of prescription drugs and seeks damages on behalf of those customers estimated to be in the hundreds of thousands across the country.
David Cutshaw, a partner at Cohen & Malad, LLP, said “It’s unfortunate that in these tough economic times, hard working Americans are being taken advantage of and charged twice for prescription drugs by CVS. Prescription drugs are high enough the way it is. This lawsuit seeks to make CVS pay refunds it owes to its customers.”
The case is currently pending in Hamilton County, Ohio, Case No. A1105191, Erickson vs. CVS Caremark Corporation.
Cohen and Malad, LLP is an Indianapolis law firm that has a record of representing classes of injured plaintiffs for over 25 years.
With offices in Cincinnati, Denver, Cody, and Phoenix, Burg Simpson is a firm of award-winning lawyers, practicing in the areas of personal injury lawsuits, class actions, medical malpractice lawsuits, dangerous drug litigation, unsafe products, insurance bad faith, employment law, commercial and securities litigation.